KVT — Krynica Vitamin SA Income Statement
0.000.00%
Last trade - 00:00- PLN155.58m
- PLN181.84m
- PLN356.27m
Annual income statement for Krynica Vitamin SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 395 | 377 | 359 | 388 | 356 |
| Cost of Revenue | |||||
| Gross Profit | 58.5 | 66.3 | 51.8 | 64.4 | 60.5 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 375 | 360 | 362 | 371 | 340 |
| Operating Profit | 20.5 | 16.7 | -3.04 | 16.8 | 16.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 21 | 14.1 | -6.74 | 13.8 | 14.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 15.6 | 13.1 | -6.68 | 12.2 | 12 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 15.6 | 13.1 | -6.68 | 12.2 | 12 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 15.6 | 13.1 | -6.68 | 12.2 | 12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.45 | 1.38 | 0.073 | 1.17 | 1.3 |
| Dividends per Share |